Rituxan May Cause Brain Disease. On December 19, 2006 Genentech issued a warning to healthcare providers for their oncology drug Rituxan, advising them that the drug has been linked to the deaths of two lupus patients from a rare brain disease, called Progressive multifocal leukoencephalopathy (PML). On November 10, 2006, Health … [Read more...]
Rituxan Side Effects Could Result In Brain Disease Lawsuits
Raptiva PML Side Effects Lawsuit
Raptiva PML Side Effect Lawsuits. Raptiva, a drug used to treat psoriasis, has been associated with a serious viral brain disease called progressive multifocal leukoencephalopathy (Progressive Multifocal Leukoencephalopathy PML). Progressive Multifocal Leukoencephalopathy PML is a rare virus that affects the central nervous system … [Read more...]
Progressive Multifocal Leukoencephalopathy Brain Infection
Gilenya May Cause Brain Infection. Our firm is investigating potential lawsuits on behalf of Gilenya users who developed progressive multifocal leukoencephalopathy (PML), a rare but serious brain infection. The U.S. Food and Drug Administration (FDA) reported cases of PML among Gilenya users in 2013, and again in August 2015. The … [Read more...]
PML Disease Injury Lawsuits
Drugs Have Been Found To Cause PML. Progressive Multifocal Leukoencephalopathy (PML) is an irregular disorder of the nervous system that mainly affects individuals with suppressed immune systems (including, allograft recipients such as kidney transplant patients; patients with cancers such as leukemia or lymphoma; and approximately … [Read more...]
Health Canada Strengthens Safety Warnings for Multiple Sclerosis Drug Gilenya
Health Canada, Canada’s health regulatory agency, has updated the label information for the multiple sclerosis drug Gilenya (fingolimod) to include stronger safety warnings on the risk of skin cancer and the rare brain infection progressive multifocal leukoencephalopathy (PML), which can be fatal. Gilenya, a prescription drug, is … [Read more...]
Tecfidera Linked to Case of PML Brain Infection
Tecfidera And Its Serious Side Effects. The multiple sclerosis drug Tecfidera has been linked to a case of a serous brain infection called progressive multifocal leukoencephalopathy (PML), the U.S. Food and Drug Administration (FDA) warned on November 25th. According to the agency's Drug Safety Communication, a patient taking … [Read more...]
Tysabri PML Risk Increases With Use
Tysabri PML Risk Increases. Tysabri, a popular treatment for relapsing multiple sclerosis (MS), is more likely to cause a serious brain infection called progressive multifocal leukoencephalopathy, or PML, the longer it is used, according to the U.S. Food & Drug Administration (FDA). The agency announced Friday that the Tysabri … [Read more...]
